Scimplify, an Indian startup that helps pharmaceutical and agricultural companies access a range of specialty chemicals, has raised $40 million in a new funding round co-led by Accel and Bertelsmann India Investments to widen its footprint in the U.S. and reach new markets.
The Series B round pegs Scimplify’s valuation at about $150 million post-money, the company said.
Specialty chemicals are vital for manufacturing in many industries, but access is still a problem, as manufacturers of these chemicals are scattered across the world….